Literature DB >> 12791319

Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease.

A Zamanou1, M Samiotaki, G Panayotou, L Margaritis, P Lymberi.   

Abstract

Current opinions suggest that autoantibodies occurring in autoimmune diseases are generated by B-cells which primarily produce polyspecific natural autoantibodies, through either polyclonal activation or specific antigen selection of these B-cells. In this study, we compared the immunological properties (polyspecificity, fine specificity and IgG subclasses) between natural anti-actin antibodies (N-AAA) and disease-associated AAA (D-AAA). IgG AAA from sera of healthy donors, patients with autoimmune hepatitis type 1 (AIH-1) and patients with primary biliary cirrhosis (PBC) were affinity-purified on actin immunoadsorbent and tested initially for polyspecificity against various cytoskeleton proteins by enzyme-linked immunosorbent assay (ELISA). Fine specificity was studied by Western blotting using proteolytic peptides of actin and by ELISA using synthetic 12 mer peptides, spanning the 221-377 aa sequence of actin. Results showed that both N-AAA and D-AAA are polyspecific. Nevertheless, D-AAA from both diseases showed a specific reactivity pattern as compared to N-AAA, against the 16 kDa C-terminal (229-377 aa) proteolytic peptide of actin and more specifically against the P36 synthetic peptide (351-362 aa). Quantitation of AAA IgG subclasses revealed that IgG1 and IgG3 were specifically increased in D-AAA from AIH-1 and PBC, respectively, as compared to N-AAA. We conclude that D-AAA are differentiated from N-AAA in terms of fine specificity and IgG subclasses, probably through specific antigen selection of B-cells primarily producing N-AAA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791319     DOI: 10.1016/s0896-8411(03)00036-2

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  6 in total

1.  Anti-actin IgA antibodies in severe coeliac disease.

Authors:  A Granito; P Muratori; F Cassani; G Pappas; L Muratori; D Agostinelli; L Veronesi; R Bortolotti; N Petrolini; F B Bianchi; U Volta
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 2.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 3.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

4.  Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1.

Authors:  Paul Guéguen; Georgios Dalekos; Jean-Baptiste Nousbaum; Kalliopi Zachou; Chaim Putterman; Pierre Youinou; Yves Renaudineau
Journal:  J Clin Immunol       Date:  2006-09-26       Impact factor: 8.542

5.  Multifunctional surfaces with discrete functionalized regions for biological applications.

Authors:  Moniraj Ghosh; Christina Alves; Ziqiu Tong; Kwadwo Tettey; Konstantinos Konstantopoulos; Kathleen J Stebe
Journal:  Langmuir       Date:  2008-06-27       Impact factor: 3.882

6.  Single cell sequencing analysis identifies genetics-modulated ORMDL3+ cholangiocytes having higher metabolic effects on primary biliary cholangitis.

Authors:  Bingyu Xiang; Chunyu Deng; Fei Qiu; Jingjing Li; Shanshan Li; Huifang Zhang; Xiuli Lin; Yukuan Huang; Yijun Zhou; Jianzhong Su; Mingqin Lu; Yunlong Ma
Journal:  J Nanobiotechnology       Date:  2021-12-06       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.